Theravance Biopharma buy melinda
Start price
03.08.17
/
50%
€32.04
Target price
26.12.17
€42.00
Performance (%)
-13.61%
End price
26.12.17
€27.68
Summary
This prediction ended on 26.12.17 with a price of €27.68. The price of Theravance Biopharma has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -13.61%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Theravance Biopharma | -1.361% | -1.361% | 51.832% | 65.714% |
| iShares Core DAX® | 2,59 % | 2,69 % | 6,41 % | 53,61 % |
| iShares Nasdaq 100 | -0,91 % | -7,37 % | 20,65 % | 72,78 % |
| iShares Nikkei 225® | 0,15 % | -10,20 % | 46,17 % | 62,43 % |
| iShares S&P 500 | -0,37 % | -0,83 % | 18,02 % | 60,74 % |
Comments by melinda for this prediction
In the thread Theravance Biopharma diskutieren
$
(Vom Mitglied beendet)
Stopped prediction by melinda for Theravance Biopharma
Theravance Biopharma
Start price
Target price
Perf. (%)
€22.20
11.03.20
11.03.20
€25.00
21.08.20
21.08.20
-29.73%
21.08.20
21.08.20
Theravance Biopharma
Start price
Target price
Perf. (%)
€25.38
10.02.18
10.02.18
€32.11
13.08.18
13.08.18
-0.43%
13.08.18
13.08.18
Theravance Biopharma
Start price
Target price
Perf. (%)
€28.90
03.08.17
03.08.17
€37.88
26.12.17
26.12.17
-13.61%
26.12.17
26.12.17


